Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does natalizumab therapy worsen neuromyelitis optica?

Literature DB >> 22914835

Does natalizumab therapy worsen neuromyelitis optica?

Anu Jacob¹, Michael Hutchinson, Liene Elsone, Siobhan Kelly, Rehiana Ali, Ivars Saukans, Niall Tubridy, Mike Boggild.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2012 PMID： 22914835 DOI： 10.1212/WNL.0b013e31826845fe

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

1. Natalizumab and the development of extensive brain lesions in neuromyelitis optica.

Authors: Maciej Juryńczyk; Krzysztof Zaleski; Krzysztof Selmaj
Journal: J Neurol Date: 2013-05-30 Impact factor: 4.849

Review 2. Neuromyelitis optica spectrum disorders.

Authors: Eoin P Flanagan; Brian G Weinshenker
Journal: Curr Neurol Neurosci Rep Date: 2014-09 Impact factor: 5.081

3. [Therapeutic options for autoimmune encephalomyelitis].

Authors: N Borisow; H Prüss; F Paul
Journal: Nervenarzt Date: 2013-04 Impact factor: 1.214

4. The clinical profile of NMOSD in Australia and New Zealand.

Authors: Wajih Bukhari; Laura Clarke; Cullen O'Gorman; Elham Khalilidehkordi; Simon Arnett; Kerri M Prain; Mark Woodhall; Roger Silvestrini; Christine S Bundell; Sudarshini Ramanathan; David Abernethy; Sandeep Bhuta; Stefan Blum; Mike Boggild; Karyn Boundy; Bruce J Brew; Wallace Brownlee; Helmut Butzkueven; William M Carroll; Celia Chen; Alan Coulthard; Russell C Dale; Chandi Das; Keith Dear; Marzena J Fabis-Pedrini; David Fulcher; David Gillis; Simon Hawke; Robert Heard; Andrew P D Henderson; Saman Heshmat; Suzanne Hodgkinson; Sofia Jimenez-Sanchez; Trevor J Kilpatrick; John King; Chris Kneebone; Andrew J Kornberg; Jeannette Lechner-Scott; Ming-Wei Lin; Christopher Lynch; Richard A L Macdonnell; Deborah F Mason; Pamela A McCombe; Jennifer Pereira; John D Pollard; Stephen W Reddel; Cameron Shaw; Judith Spies; James Stankovich; Ian Sutton; Steve Vucic; Michael Walsh; Richard C Wong; Eppie M Yiu; Michael H Barnett; Allan G Kermode; Mark P Marriott; John Parratt; Mark Slee; Bruce V Taylor; Ernest Willoughby; Robert J Wilson; Fabienne Brilot; Angela Vincent; Patrick Waters; Simon A Broadley
Journal: J Neurol Date: 2020-01-31 Impact factor: 4.849

5. Practice current: How do you treat neuromyelitis optica?

Authors: Aravind Ganesh
Journal: Neurol Clin Pract Date: 2017-04

6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors: Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal: J Neuroinflammation Date: 2016-09-27 Impact factor: 8.322

Does natalizumab therapy worsen neuromyelitis optica?

1. Natalizumab and the development of extensive brain lesions in neuromyelitis optica.

Review 2. Neuromyelitis optica spectrum disorders.

3. [Therapeutic options for autoimmune encephalomyelitis].

4. The clinical profile of NMOSD in Australia and New Zealand.

5. Practice current: How do you treat neuromyelitis optica?

6. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

7. Hindsight is 20/20.

Review 8. [Ultrahigh field MRI in context of neurological diseases].

Review 9. Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Review 10. What's new in neuromyelitis optica? A short review for the clinical neurologist.